O

OrbiMed Portfolio holdings

AUM $3.98B
1-Year Est. Return 13.05%
This Quarter Est. Return
1 Year Est. Return
+13.05%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$11.4B
AUM Growth
+$3.5B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
165
New
Increased
Reduced
Closed

Top Buys

1
+$405M
2
+$338M
3
+$153M
4
UNH icon
UnitedHealth
UNH
+$137M
5
PFE icon
Pfizer
PFE
+$133M

Top Sells

1
+$315M
2
+$67.6M
3
+$66.4M
4
EXEL icon
Exelixis
EXEL
+$58.8M
5
BIIB icon
Biogen
BIIB
+$45.7M

Sector Composition

1 Healthcare 98.28%
2 Financials 0.52%
3 Technology 0.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$1.12B 9.76%
15,594,877
2
$537M 4.7%
7,406,307
3
$451M 3.95%
7,330,423
4
$405M 3.54%
+8,740,887
5
$338M 2.96%
+8,400,768
6
$335M 2.93%
2,745,327
7
$319M 2.79%
13,822,463
8
$308M 2.7%
6,645,100
9
$252M 2.2%
1,145,300
-171,700
10
$235M 2.05%
6,523,000
+1,675,700
11
$220M 1.93%
3,549,100
12
$220M 1.93%
3,008,755
13
$218M 1.9%
2,786,946
+73,569
14
$210M 1.84%
2,110,700
15
$197M 1.73%
834,100
+168,000
16
$178M 1.56%
348,145
17
$171M 1.5%
6,073,850
+1,400,000
18
$158M 1.38%
5,477,958
19
$153M 1.34%
+3,847,929
20
$137M 1.2%
+390,300
21
$133M 1.16%
+3,616,600
22
$130M 1.14%
319,703
23
$130M 1.13%
529,400
-186,500
24
$125M 1.09%
1,301,715
25
$120M 1.05%
1,993,700
+658,000
1
2 3 4 5